SCN10A and cardiomyopathy: Furthermore, higher expression of the rate-limiting enzyme of noradrenaline synthesis (Th) suggested that cardiac SNS activity was increased in DOX-treated mice, and the result fits with previous work showing DOX to upregulate TH protein level and linking DOX-induced cardiomyopathy to increased SNS activity [3, 4, 46].